Key Quantitative Figures

  • Number of shares allotted: 2920 equity shares of ₹1.00 face value each
  • Total money realized: ₹69,360 from exercise of options
  • Exercise price breakdown: 1000 shares at ₹67.44 per share and 1920 shares at ₹1 per share
  • Paid-up share capital change: Increased from ₹29,51,95,658 (29,51,95,658 shares) to ₹29,51,98,578 (29,51,98,578 shares)
  • EPS data: Basic EPS - ₹9.19, Diluted EPS - ₹9.18 (unaudited financial results for quarter ended June 30, 2026)

Dates of Action

  • Committee approval date: October 13, 2026 (via circulation)
  • Allotment date: October 13, 2026

Parties Involved

  • Approving authority: Business & Resource Committee of the Board
  • Stock exchanges: National Stock Exchange of India Limited, BSE Limited

Scheme Details

  • Scheme name: Five-Star Associate Stock Option Scheme, 2018
  • Regulatory status: Scheme instituted prior to IPO, amended in line with SEBI SBEB Regulations 2021
  • Shareholder approvals: Approved at Extra-ordinary general meeting held on October 8, 2021 and ratified at Annual General Meeting held on September 16, 2023
  • Exchange approvals: In-principal approval obtained from National Stock Exchange & Bombay Stock Exchange

Terms and Conditions

  • Exercise period: Commences from vesting date and expires not later than 60 months from relevant vesting date
  • Pricing formula: Exercise price per option not less than face value, determined by Nomination & Remuneration Committee
  • Share ranking: Allotted shares shall rank pari-passu with existing equity shares of the Company

Current Status

  • The Company is in the process of completing other formalities with respect to listing of the allotted shares
  • Details pursuant to SEBI Master Circular dated January 30, 2026 have been enclosed with the filing